Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name LY3022855
Trade Name
Synonyms IMC-CS4
Drug Descriptions

LY3022855 (IMC-CS4) is a monoclonal antibody against colony stimulating factor 1 receptor (CSF1R), which potentially induces antibody-dependent cell-mediated cytotoxicity (ADCC) in tumor cells over expressing CSF1R (NCI Drug Dictionary).

DrugClasses CSF1R Antibody 4
CAS Registry Number NA
NCIT ID C96801


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Cobimetinib + LY3022855 + Vemurafenib Cobimetinib LY3022855 Vemurafenib 0 1
Cyclophosphamide + GVAX pancreatic cancer vaccine + LY3022855 + Pembrolizumab Cyclophosphamide GVAX pancreatic cancer vaccine LY3022855 Pembrolizumab 0 1
Durvalumab + LY3022855 Durvalumab LY3022855 0 1
LY3022855 LY3022855 0 2
LY3022855 + Tremelimumab LY3022855 Tremelimumab 0 1

Additional content available in CKB BOOST